ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).
作者信息
Stoop Thomas F, Augustinus Simone, Andersson Bodil, Ghorbani Poya, Wellner Ulrich F, Uhl Waldemar, Besselink Marc G, Pitt Henry A, Del Chiaro Marco
机构信息
Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Amsterdam UMC, Location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands.
出版信息
Ann Surg Oncol. 2024 Nov;31(12):8354-8355. doi: 10.1245/s10434-024-16021-1. Epub 2024 Aug 19.
Abstract
摘要
相似文献
1
ASO Author Reflections: Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).ASO作者反思：胰腺癌行与不行门静脉肠系膜静脉切除的远端胰腺切除术：北美、德国、瑞典和荷兰患者的跨大西洋评估（GAPASURG）
Ann Surg Oncol. 2024 Nov;31(12):8354-8355. doi: 10.1245/s10434-024-16021-1. Epub 2024 Aug 19.
2
Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).胰体尾切除术伴或不伴肠系膜上静脉切除治疗胰腺腺癌患者的手术效果：北美、德国、瑞典和荷兰（GAPASURG）的患者跨大西洋评估。
Ann Surg Oncol. 2024 Nov;31(12):8327-8339. doi: 10.1245/s10434-024-15932-3. Epub 2024 Aug 9.
3
International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis.国际间在微创和开放远端胰腺切除术的选择和结果上的差异：一项跨大西洋分析。
Surgery. 2024 Oct;176(4):1198-1206. doi: 10.1016/j.surg.2024.06.028. Epub 2024 Jul 16.
4
Portal vein resection in pancreatic head carcinoma. Part 1: Technical considerations.胰头癌的门静脉切除。第1部分：技术要点。
Hepatogastroenterology. 2001 May-Jun;48(39):884-7.
5
Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.肠系膜和门静脉切除的胰切除术治疗可切除边缘性胰腺癌：406例患者的多中心研究
Ann Surg Oncol. 2016 Jun;23(6):2028-37. doi: 10.1245/s10434-016-5123-5. Epub 2016 Feb 18.
6
[Is pancreatectomy with resection of the retro-pancreatic vessels for cancer justified?].[胰腺癌行胰切除术并切除胰后血管是否合理？]
Chirurgie. 1998 Nov;123(5):438-44. doi: 10.1016/s0001-4001(99)80069-5.
7
Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.伴有静脉受累的胰腺腺癌： upfront同步门静脉-肠系膜上静脉切除仍合理吗？法国外科协会的一项调查
Ann Surg Oncol. 2015;22(6):1874-83. doi: 10.1245/s10434-014-4304-3. Epub 2015 Feb 10.
8
Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.重新评估门静脉-肠系膜上静脉侵犯在临界可切除胰腺癌中的临床意义。
Eur J Surg Oncol. 2017 Jun;43(6):1068-1075. doi: 10.1016/j.ejso.2017.03.020. Epub 2017 Apr 8.
9
Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.胰腺癌胰腺切除术后伴有静脉切除的患者静脉切缘处癌细胞的意义。
J Gastrointest Surg. 2020 Feb;24(2):368-379. doi: 10.1007/s11605-019-04126-y. Epub 2019 Feb 28.
10
Defining venous involvement in borderline resectable pancreatic cancer.界定可切除性边缘性胰腺癌中的静脉受累情况。
Ann Surg Oncol. 2010 Nov;17(11):2832-8. doi: 10.1245/s10434-010-1284-9. Epub 2010 Aug 20.
本文引用的文献
1
Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG).胰体尾切除术伴或不伴肠系膜上静脉切除治疗胰腺腺癌患者的手术效果：北美、德国、瑞典和荷兰（GAPASURG）的患者跨大西洋评估。
Ann Surg Oncol. 2024 Nov;31(12):8327-8339. doi: 10.1245/s10434-024-15932-3. Epub 2024 Aug 9.
2
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer.局部进展期和交界可切除胰腺癌患者的术前化疗、放疗和手术决策。
Nat Rev Gastroenterol Hepatol. 2024 Feb;21(2):101-124. doi: 10.1038/s41575-023-00856-2. Epub 2023 Nov 30.
3
Technical Strategy for Pancreatic Body Cancers: A Raison d'etre of Distal Pancreatectomy with Portal Resection.胰体癌的技术策略：门静脉切除的远端胰腺切除术的存在理由。
Ann Surg Oncol. 2024 Feb;31(2):1347-1357. doi: 10.1245/s10434-023-14554-5. Epub 2023 Nov 11.
4
Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis.胰腺癌的静脉切除：一种安全可行的选择？一项系统评价与荟萃分析。
Pancreatology. 2022 Sep;22(6):803-809. doi: 10.1016/j.pan.2022.05.001. Epub 2022 May 29.
5
Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.胰腺导管腺癌（头、体、尾）部位与肿瘤分期、治疗和生存的关系：基于人群的分析。
Acta Oncol. 2018 Dec;57(12):1655-1662. doi: 10.1080/0284186X.2018.1518593. Epub 2018 Sep 28.
Zotero 插件